Prostate Cancer

Oncology·MeSH: Prostatic Neoplasms

Prevalence

256.0 / 100K

Incidence

111.0 / 100K/yr

467 drugs in development·93 companies·191 clinical trials

Drug Pipeline by Phase

Approved(25)
Phase 3(100)
DrugCompany
[177Lu]Lu-DOTA-TATENovartis AG (NVS)
[18F]PSMA-1007 InjectionUNITED THERAPEUTICS Corp (UTHR)
[68ga]ga-psma-11Novartis AG (NVS)
[Lu-177]-PNT2002ELI LILLY & Co (LLY)
177lu-pnt2002POINT Biopharma Global Inc. (PNT)
177lu-psma-617ENDOCYTE INC (ECYT)
177lu-tlx591Telix Pharmaceuticals Ltd (TLPPF)
177lu-tlx591Telix Pharmaceuticals Limited (TLX)
aaa617Novartis AG (NVS)
aaa817Novartis AG (NVS)
AAA817Merus N.V. (MRUS)
abirateroneGH Research PLC (GHRS)
abirateroneTelix Pharmaceuticals Limited (TLX)
abirateroneTelix Pharmaceuticals Ltd (TLPPF)
AbirateroneELI LILLY & Co (LLY)
Abiraterone acetateMerck & Co., Inc. (MRK)
ADT + NHTKYNTRA BIO INC. (KYNB)
ADT plus continued ARPIKYNTRA BIO INC. (KYNB)
ADT plus only 12 months of ARPIKYNTRA BIO INC. (KYNB)
androgen deprivation therapyCTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
androgen deprivation therapyCHINA PHARMA HOLDINGS, INC. (CPHI)
Androgen Deprivation TherapyASTRAZENECA PLC (AZN)
Androgen-deprivation TherapyMyovant Sciences Ltd. (MYOV)
ApalutamideCrinetics Pharmaceuticals, Inc. (CRNX)
Apalutamide 60 mg or 240 mg tabletsKYNTRA BIO INC. (KYNB)
ardtNovartis AG (NVS)
ARDTNovartis AG (NVS)
arn-509CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH)
arpiNovartis AG (NVS)
ARPIMerus N.V. (MRUS)
AZD0516ASTRAZENECA PLC (AZN)
AZD0754ASTRAZENECA PLC (AZN)
azd2265ASTRAZENECA PLC (AZN)
AZD2275ASTRAZENECA PLC (AZN)
AZD2284ASTRAZENECA PLC (AZN)
AZD2287ASTRAZENECA PLC (AZN)
AZD5305ASTRAZENECA PLC (AZN)
azd8359ASTRAZENECA PLC (AZN)
BicalutamideMyovant Sciences Ltd. (MYOV)
BMS-986365KYNTRA BIO INC. (KYNB)
brachytherapyGH Research PLC (GHRS)
CabazitaxelASTRAZENECA PLC (AZN)
Cabazitaxel 60 mg Solution for InjectionKYNTRA BIO INC. (KYNB)
CAN-2409Candel Therapeutics, Inc. (CADL)
Ciprofloxacin 500gUNITED THERAPEUTICS Corp (UTHR)
cMABKYNTRA BIO INC. (KYNB)
Darolutamide plus ADT treatmentRoyalty Pharma plc (RPRX)
Darotamine CapsuleKYNTRA BIO INC. (KYNB)
Degarelix & RelugolixKYNTRA BIO INC. (KYNB)
EnzalutamideELI LILLY & Co (LLY)
EnzalutamideARS Pharmaceuticals, Inc. (SPRY)
EnzalutamideMyovant Sciences Ltd. (MYOV)
EnzalutamideMerck & Co., Inc. (MRK)
Fludrocortisone acetateMerck & Co., Inc. (MRK)
FlutamideMyovant Sciences Ltd. (MYOV)
gonadotropin-releasing hormone analoguesNOVARTIS AG (NVSEF)
goserelinKYNTRA BIO INC. (KYNB)
Goserelin, Histrelin, Leuprolide & TriptorelinKYNTRA BIO INC. (KYNB)
HRS-4357 injectionKYNTRA BIO INC. (KYNB)
HS-20093 for InjectionKYNTRA BIO INC. (KYNB)
HydrocortisoneMerck & Co., Inc. (MRK)
HydrocortisoneMerus N.V. (MRUS)
iMABKYNTRA BIO INC. (KYNB)
LenvatinibMerck & Co., Inc. (MRK)
leuprolide open labelPFIZER INC (PFE)
leuprorelinPFIZER INC (PFE)
LuprolideKYNTRA BIO INC. (KYNB)
luteinizing hormone-releasing hormone analogGH Research PLC (GHRS)
MetronidazoleMyovant Sciences Ltd. (MYOV)
mevrometostatPFIZER INC (PFE)
New Formulation of Niraparib and Abiraterone AcetateJanux Therapeutics, Inc. (JANX)
NilutamideMyovant Sciences Ltd. (MYOV)
NiraparibMyovant Sciences Ltd. (MYOV)
NiraparibARS Pharmaceuticals, Inc. (SPRY)
NiraparibJanux Therapeutics, Inc. (JANX)
OlaparibKYNTRA BIO INC. (KYNB)
OpevesostatMerus N.V. (MRUS)
OpevesostatMerck & Co., Inc. (MRK)
PARP Inhibitors and Other Systemic AgentsKYNTRA BIO INC. (KYNB)
pasritamigZymeworks Inc. (ZYME)
pnt2002POINT Biopharma Global Inc. (PNT)
PNT2002Lantheus Holdings, Inc. (LNTH)
Ra223KYNTRA BIO INC. (KYNB)
Radium Chloride Ra-223KYNTRA BIO INC. (KYNB)
radium-223ASTRAZENECA PLC (AZN)
regn15505REGENERON PHARMACEUTICALS, INC. (REGN)
regn4336REGENERON PHARMACEUTICALS, INC. (REGN)
regn5678REGENERON PHARMACEUTICALS, INC. (REGN)
RelugolixMyovant Sciences Ltd. (MYOV)
Relugolix Combination TabletMyovant Sciences Ltd. (MYOV)
RucaparibKYNTRA BIO INC. (KYNB)
TalazoparibPFIZER INC (PFE)
talazoparib plus enzalutamidePFIZER INC (PFE)
TislelizumabKYNTRA BIO INC. (KYNB)
topsalysinSOPHIRIS BIO INC. (SPHS)
trametinibKYNTRA BIO INC. (KYNB)
treatment armSPRING PHARMACEUTICAL GROUP, INC. (CYIG)
Ultra-Short-Term Androgen Deprivation Therapy with RelugolixRoyalty Pharma plc (RPRX)
XaluritamigXencor Inc (XNCR)
zilovertamabOncternal Therapeutics, Inc. (ONCT)
Phase 2(108)
DrugCompany
[177Lu]Lu-DOTATATENovartis AG (NVS)
111In-J591UNITED THERAPEUTICS Corp (UTHR)
177Lu-J591UNITED THERAPEUTICS Corp (UTHR)
18F-DCFPyLKYNTRA BIO INC. (KYNB)
68ga-psma-11Novartis AG (NVS)
68Ga-PSMA-11Novartis AG (NVS)
AAA617Novartis AG (NVS)
AbirateroneNovartis AG (NVS)
Abiraterone acetateUNITED THERAPEUTICS Corp (UTHR)
Abiraterone AcetateENANTA PHARMACEUTICALS INC (ENTA)
acer-801Acer Therapeutics Inc. (ACER)
adxs-psaOLD AYALA, INC (AYLA)
ADXS-PSAAyala Pharmaceuticals, Inc. (ADXS)
aglatimagene besadenovecCandel Therapeutics, Inc. (CADL)
aglatimagene besadenovec + valacyclovirCandel Therapeutics, Inc. (CADL)
androgen receptor signal inhibitorGH Research PLC (GHRS)
ARPINovartis AG (NVS)
autologous skin fibroblastsUNITED THERAPEUTICS Corp (UTHR)
AZD6621ASTRAZENECA PLC (AZN)
AZD9574ASTRAZENECA PLC (AZN)
BicalutamideENANTA PHARMACEUTICALS INC (ENTA)
BicalutamideJanux Therapeutics, Inc. (JANX)
bxcl701 monotherapyBioXcel Therapeutics, Inc. (BTAI)
CemiplimabUNITED THERAPEUTICS Corp (UTHR)
Dabrafenib plus TrametinibPFIZER INC (PFE)
DarolutamideNovartis AG (NVS)
dasatinibKYNTRA BIO INC. (KYNB)
DegarelixENANTA PHARMACEUTICALS INC (ENTA)
DegarelixJanux Therapeutics, Inc. (JANX)
DegarelixRoyalty Pharma plc (RPRX)
DegarelixMyovant Sciences Ltd. (MYOV)
DFMOKYNTRA BIO INC. (KYNB)
eflornithinePANBELA THERAPEUTICS, INC. (SNBP)
ELIGARDMyovant Sciences Ltd. (MYOV)
ELIGARDJanux Therapeutics, Inc. (JANX)
EnhertuKYNTRA BIO INC. (KYNB)
EnoblituzumabMACROGENICS INC (MGNX)
env 105Kairos Pharma, LTD. (KAPA)
EnzalutamideBRISTOL MYERS SQUIBB CO (BMY)
EnzalutamideNovartis AG (NVS)
EnzalutamideUNITED THERAPEUTICS Corp (UTHR)
EPI-7386KYNTRA BIO INC. (KYNB)
ETBX-071ImmunityBio, Inc. (IBRX)
EtoposideMerck & Co., Inc. (MRK)
etrumadenantArcus Biosciences, Inc. (RCUS)
etrumadenantCoherus Oncology, Inc. (CHRS)
etrumadenantArcus Biosciences, Inc. (RCUS)
EtrumadenantArcus Biosciences, Inc. (RCUS)
FG-3246KYNTRA BIO INC. (KYNB)
FLT PET/CTUNITED THERAPEUTICS Corp (UTHR)
FlutamideJanux Therapeutics, Inc. (JANX)
FlutamideENANTA PHARMACEUTICALS INC (ENTA)
fpi-2265Fusion Pharmaceuticals Inc. (FUSN)
Genetic SNP profilingUNITED THERAPEUTICS Corp (UTHR)
GnRH analogKYNTRA BIO INC. (KYNB)
Goserelin AcetateJanux Therapeutics, Inc. (JANX)
HydrocortisoneUNITED THERAPEUTICS Corp (UTHR)
i-131-1095ARS Pharmaceuticals, Inc. (SPRY)
i-131-1095PROGENICS PHARMACEUTICALS INC (PGNX)
InavolisibKYNTRA BIO INC. (KYNB)
induction therapyNovartis AG (NVS)
jsb462Novartis AG (NVS)
JSB462Novartis AG (NVS)
JSB462 Dose 1 QDNovartis AG (NVS)
jsb462 qdNovartis AG (NVS)
KetoconazoleUNITED THERAPEUTICS Corp (UTHR)
LenvatinibMerus N.V. (MRUS)
lp-100Lantern Pharma Inc. (LTRN)
Luteinizing hormone-releasing hormone analogueKYNTRA BIO INC. (KYNB)
LY2157299KYNTRA BIO INC. (KYNB)
M-CENKImmunityBio, Inc. (IBRX)
MethylphenidateCOLLEGIUM PHARMACEUTICAL, INC (COLL)
MethylphenidateJanux Therapeutics, Inc. (JANX)
MethylphenidateRoyalty Pharma plc (RPRX)
MetronidazoleRoyalty Pharma plc (RPRX)
MetronidazoleARS Pharmaceuticals, Inc. (SPRY)
MetronidazoleUNITED THERAPEUTICS Corp (UTHR)
MetronidazoleJanux Therapeutics, Inc. (JANX)
New Hormonal AgentKYNTRA BIO INC. (KYNB)
NilutamideENANTA PHARMACEUTICALS INC (ENTA)
NilutamideJanux Therapeutics, Inc. (JANX)
OlaparibJanux Therapeutics, Inc. (JANX)
Omeprazole 80 mg twice dailyJanux Therapeutics, Inc. (JANX)
pds01adcPDS Biotechnology Corp (PDSB)
PDS01ADCKYNTRA BIO INC. (KYNB)
PegfilgrastimKYNTRA BIO INC. (KYNB)
RucaparibBRISTOL MYERS SQUIBB CO (BMY)
SHR2554 TabletKYNTRA BIO INC. (KYNB)
SHR3680 TabletKYNTRA BIO INC. (KYNB)
Sipuleucel-TKYNTRA BIO INC. (KYNB)
srf617Coherus Oncology, Inc. (CHRS)
sunphenonGH Research PLC (GHRS)
SX-682KYNTRA BIO INC. (KYNB)
TalazoparibKYNTRA BIO INC. (KYNB)
testosterone cypionateKYNTRA BIO INC. (KYNB)
Testosterone cypionateUNITED THERAPEUTICS Corp (UTHR)
Testosterone CypionateMyovant Sciences Ltd. (MYOV)
Testosterone enanthateKYNTRA BIO INC. (KYNB)
Testosterone enanthateUNITED THERAPEUTICS Corp (UTHR)
Testosterone UndecanoateKYNTRA BIO INC. (KYNB)
TivozanibKYNTRA BIO INC. (KYNB)
Transdermal TestosteroneKYNTRA BIO INC. (KYNB)
Ultra-Short-Term Androgen Deprivation Therapy with RelugolixJanux Therapeutics, Inc. (JANX)
vudalimabXencor Inc (XNCR)
vudalimab monotherapyXencor Inc (XNCR)
YS5 antibodyUNITED THERAPEUTICS Corp (UTHR)
ZEN-3694KYNTRA BIO INC. (KYNB)
zimberelimabCoherus Oncology, Inc. (CHRS)
Phase 1(96)
DrugCompany
[177lu]lu-psma-617Novartis AG (NVS)
[177Lu]Lu-PSMA-617Novartis AG (NVS)
[²¹²Pb]Pb-ADVC001Janux Therapeutics, Inc. (JANX)
[²¹²Pb]Pb-ADVC001Royalty Pharma plc (RPRX)
[225ac]ac-aky-2519Aktis Oncology Inc. (AKTS)
[64cu]cu-aky-2519Aktis Oncology Inc. (AKTS)
[68ga]ga-nns309Novartis AG (NVS)
[68ga]ga-psma-11Novartis AG (NVS)
177lu-dfc413Novartis AG (NVS)
225Ac-J591KYNTRA BIO INC. (KYNB)
68ga-nns309Novartis AG (NVS)
89Zr-DFO-YS5UNITED THERAPEUTICS Corp (UTHR)
ABBV-969AbbVie Inc. (ABBV)
abirateroneAMGEN INC (AMGN)
abiraterone acetate 250 mg orOric Pharmaceuticals, Inc. (ORIC)
adi-212Adicet Bio, Inc. (ACET)
adxs-504OLD AYALA, INC (AYLA)
ADXS-504Ayala Pharmaceuticals, Inc. (ADXS)
amg 509AMGEN INC (AMGN)
androgen deprivation therapyNOVARTIS AG (NVSEF)
androgen deprivation therapyNovartis AG (NVS)
antiemetics & antinauseantsNOVARTIS AG (NVSEF)
antiemetics & antinauseantsNovartis AG (NVS)
ApalutamideMerus N.V. (MRUS)
apalutamide 60 mg orOric Pharmaceuticals, Inc. (ORIC)
ARRxKYNTRA BIO INC. (KYNB)
ART26.12ARTELO BIOSCIENCES, INC. (ARTL)
arx517Ambrx Biopharma Cayman, Inc. (AMAM)
arx517GH Research PLC (GHRS)
ARX517Royalty Pharma plc (RPRX)
ARX517Merus N.V. (MRUS)
ARX517Myovant Sciences Ltd. (MYOV)
ARX517ARS Pharmaceuticals, Inc. (SPRY)
ARX517Janux Therapeutics, Inc. (JANX)
BavdegalutamideARVINAS, INC. (ARVN)
BNT112BioNTech SE (BNTX)
bpx-601REGENERON PHARMACEUTICALS, INC. (REGN)
CCS1477KYNTRA BIO INC. (KYNB)
CemiplimabBioNTech SE (BNTX)
CobicistatKYNTRA BIO INC. (KYNB)
CPI-1205KYNTRA BIO INC. (KYNB)
DarolutamideJanux Therapeutics, Inc. (JANX)
Darolutamide plus ADT treatmentJanux Therapeutics, Inc. (JANX)
DegarelixELI LILLY & Co (LLY)
DegarelixUNITED THERAPEUTICS Corp (UTHR)
ec1169ENDOCYTE INC (ECYT)
engineered autologous T cellsUNITED THERAPEUTICS Corp (UTHR)
enzalutamide 40 mg capsules or 40 mg andOric Pharmaceuticals, Inc. (ORIC)
FianlimabUNITED THERAPEUTICS Corp (UTHR)
FOR46KYNTRA BIO INC. (KYNB)
gnrh antagonistAMGEN INC (AMGN)
gnrh antagonistsNovartis AG (NVS)
gnrh antagonistsNOVARTIS AG (NVSEF)
GNRH-A Leuprolide AcetateELI LILLY & Co (LLY)
gonadotropin-releasing hormone analoguesNovartis AG (NVS)
inr731Novartis AG (NVS)
inr731NOVARTIS AG (NVSEF)
JANX007Janux Therapeutics, Inc. (JANX)
janx014Janux Therapeutics, Inc. (JANX)
JNJ-9401Xencor Inc (XNCR)
JSB462 QDMerus N.V. (MRUS)
lava-1207LAVA Therapeutics NV (LVTX)
lava-1266LAVA Therapeutics NV (LVTX)
lava-1427LAVA Therapeutics NV (LVTX)
Lopinavir and Ritonavir TabletsKYNTRA BIO INC. (KYNB)
NUV-1156Nuvation Bio Inc. (NUVB)
onct-534Oncternal Therapeutics, Inc. (ONCT)
oric-533Oric Pharmaceuticals, Inc. (ORIC)
oric-944Oric Pharmaceuticals, Inc. (ORIC)
ORIC-944KYNTRA BIO INC. (KYNB)
pf-06821497PFIZER INC (PFE)
pTVG-ARUNITED THERAPEUTICS Corp (UTHR)
QLC5508KYNTRA BIO INC. (KYNB)
QLH12016KYNTRA BIO INC. (KYNB)
QuemliclustatArcus Biosciences, Inc. (RCUS)
RelacorilantKYNTRA BIO INC. (KYNB)
rinzimetostatOric Pharmaceuticals, Inc. (ORIC)
tagmokitugCoherus Oncology, Inc. (CHRS)
tazemetostatEpizyme, Inc. (EPZM)
TelmisartanKYNTRA BIO INC. (KYNB)
TinengotinibKYNTRA BIO INC. (KYNB)
TinengotinibARS Pharmaceuticals, Inc. (SPRY)
TinengotinibJanux Therapeutics, Inc. (JANX)
TinengotinibRoyalty Pharma plc (RPRX)
TinengotinibMyovant Sciences Ltd. (MYOV)
TQB3201 tabletsKYNTRA BIO INC. (KYNB)
Tulmimetostat DL1 QDMerus N.V. (MRUS)
Tulmimetostat DL2 QDMerus N.V. (MRUS)
Tulmimetostat DL3 QDMerus N.V. (MRUS)
Tulmimetostat Doses 1 or 2 QDMerus N.V. (MRUS)
Tulmimetostat RP2D QDMerus N.V. (MRUS)
vir-5500Vir Biotechnology, Inc. (VIR)
VIR-5500KYNTRA BIO INC. (KYNB)
VTP-850Barinthus Biotherapeutics plc. (BRNS)
xaluritamigAMGEN INC (AMGN)
XNW5004KYNTRA BIO INC. (KYNB)
Phase 1/Phase 2(54)
DrugCompany
[177lu]lu-dota-tateNovartis AG (NVS)
[177lu]lu-neobNovartis AG (NVS)
[68ga]ga-dota-tateNovartis AG (NVS)
[68Ga]Ga-DOTA-TATENovartis AG (NVS)
[68ga]ga-neobNovartis AG (NVS)
[68ga]ga-neobNovartis AG (NVS)
161tb rad402Radiopharm Theranostics Limited (RADX)
161tb rad402Radiopharm Theranostics Ltd (RDPTF)
177lu-betabartRadiopharm Theranostics Limited (RADX)
177lu-fap-2286Novartis AG (NVS)
225ac-psma-r2Novartis AG (NVS)
68ga-fap-2286Novartis AG (NVS)
aaa602Novartis AG (NVS)
aaa802Novartis AG (NVS)
abirateroneNovartis AG (NVS)
abirateroneVERTEX PHARMACEUTICALS INC / MA (VRTX)
abirateroneCONSTELLATION PHARMACEUTICALS INC (CNST)
amo959Novartis AG (NVS)
AMO959Novartis AG (NVS)
ARV-110ARVINAS, INC. (ARVN)
arv-766 + abiraterone part c&dNovartis AG (NVS)
arv-766 part a&bNovartis AG (NVS)
BNT324BioNTech SE (BNTX)
bpx-601BELLICUM PHARMACEUTICALS, INC (BLCM)
cpi-1205CONSTELLATION PHARMACEUTICALS INC (CNST)
cpi-1205VERTEX PHARMACEUTICALS INC / MA (VRTX)
exicorilantCORCEPT THERAPEUTICS INC (CORT)
flotufolastat f 18Novartis AG (NVS)
ft-7051Forma Therapeutics Holdings, Inc. (FMTX)
gallium gozetotideNovartis AG (NVS)
ifinatamab deruxtecanMerck & Co., Inc. (MRK)
jsb462 dose 1 qdNovartis AG (NVS)
jsb462 dose 2 qdNovartis AG (NVS)
JSB462 Dose 2 QDNovartis AG (NVS)
JSB462 QDNovartis AG (NVS)
oric-114 dose 1 + amivantamabOric Pharmaceuticals, Inc. (ORIC)
oric-114 dose 2 + amivantamabOric Pharmaceuticals, Inc. (ORIC)
oric-114 dose 3 + amivantamabOric Pharmaceuticals, Inc. (ORIC)
piflufolastatNovartis AG (NVS)
psma-1007Novartis AG (NVS)
regn15505+regn4336REGENERON PHARMACEUTICALS, INC. (REGN)
SX-682UNITED THERAPEUTICS Corp (UTHR)
tulmimetostatNovartis AG (NVS)
TulmimetostatNovartis AG (NVS)
tulmimetostat dl1 qdNovartis AG (NVS)
Tulmimetostat DL1 QDNovartis AG (NVS)
tulmimetostat dl2 qdNovartis AG (NVS)
Tulmimetostat DL2 QDNovartis AG (NVS)
tulmimetostat dl3 qdNovartis AG (NVS)
Tulmimetostat DL3 QDNovartis AG (NVS)
tulmimetostat doses 1 or 2 qdNovartis AG (NVS)
Tulmimetostat Doses 1 or 2 QDNovartis AG (NVS)
tulmimetostat rp2d qdNovartis AG (NVS)
Tulmimetostat RP2D QDNovartis AG (NVS)
Phase 2/Phase 3(1)
Phase 4(56)
DrugCompany
[177lu]lu-neobNovartis AG (NVS)
AAA817Novartis AG (NVS)
abirateroneASTRAZENECA PLC (AZN)
abirateronePFIZER INC (PFE)
AbirateroneKYNTRA BIO INC. (KYNB)
Abiraterone acetateKYNTRA BIO INC. (KYNB)
Abiraterone AcetateASTRAZENECA PLC (AZN)
Abiraterone acetate 250 mg or 500 mg tabletsKYNTRA BIO INC. (KYNB)
Abiraterone Oral TabletKYNTRA BIO INC. (KYNB)
ADT + ApalutamideKYNTRA BIO INC. (KYNB)
ADT + EnzalutamideKYNTRA BIO INC. (KYNB)
ADT + Nilutamide, Flutamide, & BicalutamideKYNTRA BIO INC. (KYNB)
androgen deprivation therapyGH Research PLC (GHRS)
Androgen Deprivation TherapyKYNTRA BIO INC. (KYNB)
Androgen-deprivation TherapyJanux Therapeutics, Inc. (JANX)
ApalutamideKYNTRA BIO INC. (KYNB)
ApalutamideUNITED THERAPEUTICS Corp (UTHR)
ApalutamideASTRAZENECA PLC (AZN)
ApalutamideRoyalty Pharma plc (RPRX)
BicalutamideRoyalty Pharma plc (RPRX)
BrachytherapyKYNTRA BIO INC. (KYNB)
DarolutamideASTRAZENECA PLC (AZN)
DarolutamideKYNTRA BIO INC. (KYNB)
DarolutamideMyovant Sciences Ltd. (MYOV)
Darolutamide Oral TabletMyovant Sciences Ltd. (MYOV)
Darolutamide Oral TabletJanux Therapeutics, Inc. (JANX)
Darolutamide plus ADT treatmentMyovant Sciences Ltd. (MYOV)
EnzalutamideRoyalty Pharma plc (RPRX)
EnzalutamideKYNTRA BIO INC. (KYNB)
EnzalutamideASTRAZENECA PLC (AZN)
Enzalutamide Oral CapsuleKYNTRA BIO INC. (KYNB)
Enzalutamide Soft CapsulesKYNTRA BIO INC. (KYNB)
Enzalutamide;AbirateroneKYNTRA BIO INC. (KYNB)
EPI-7386 with EnzalutamideKYNTRA BIO INC. (KYNB)
FlutamideRoyalty Pharma plc (RPRX)
Gonadotropin Releasing Hormone AgonistsKYNTRA BIO INC. (KYNB)
Hormone therapy or chemotherapyKYNTRA BIO INC. (KYNB)
LeuprolideMyovant Sciences Ltd. (MYOV)
leuprorelinMyovant Sciences Ltd. (MYOV)
leuprorelinJanux Therapeutics, Inc. (JANX)
Lu-17-PSMA-617Novartis AG (NVS)
Luteinizing Hormone Releasing HormoneKYNTRA BIO INC. (KYNB)
Memantine HydrochlorideKYNTRA BIO INC. (KYNB)
Myfembree Oral ProductMyovant Sciences Ltd. (MYOV)
NAH therapyKYNTRA BIO INC. (KYNB)
Neoadjuvant olaparibASTRAZENECA PLC (AZN)
NilutamideRoyalty Pharma plc (RPRX)
OlaparibASTRAZENECA PLC (AZN)
PRL-02 injectionKYNTRA BIO INC. (KYNB)
Prostate cancer risk gene panelUNITED THERAPEUTICS Corp (UTHR)
Radium-223 dichlorideKYNTRA BIO INC. (KYNB)
rezvilutamideASTRAZENECA PLC (AZN)
Rezvilutamide TabletsKYNTRA BIO INC. (KYNB)
saruparibASTRAZENECA PLC (AZN)
Talazoparib with enzalutamideKYNTRA BIO INC. (KYNB)
Vancomycin and TobramycinUNITED THERAPEUTICS Corp (UTHR)

Compare drugs

Frequently asked questions

How many drugs are in development for Prostate Cancer?

BioSniper tracks 467 drugs in development for Prostate Cancer across 93 companies.

How many clinical trials target Prostate Cancer?

There are 191 clinical trials targeting Prostate Cancer tracked by BioSniper.

What is the prevalence of Prostate Cancer?

The estimated prevalence of Prostate Cancer is approximately 256.0 per 100,000 population.

Deep-dive into Prostate Cancer

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis